← Leaderboards
Alexander I. Agoulnik
Baylor College Of Medicine
$7,344,882
Attributed
$7,762,536
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $761.6K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,762,536 · 10
By mechanism
R01$5,209,383 · 3
R21$1,106,467 · 3
U01$585,716 · 1
P01$527,262 · 1
R41$308,708 · 1
R03$25,000 · 1
Top collaborators
- Irina Agoulnik3 shared
- Peter S Distefano1 shared
- Ronald Lindsay1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Dolores Jean Lamb$15,622,235
- Santosh A Helekar$597,931
- Antonio Baldini$7,665,125
- Delores J Lamb$1,700,919
- Adrian Philip Gee$19,740,990
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionResponseG-Protein-Coupled ReceptorsReceptorRelaxinIn VivoMaleDesignSeriesAgonistFutureRelaxin ReceptorLaboratoriesBasePeptidesAnimal ModelSmall MoleculeCryptorchidismProductionGene ExpressionIn VitroPhenotypeAffectExtracellular Matrix
Grant awards (31)
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor$199,856
R21 · FY2024 · CA
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor$172,391
R21 · FY2023 · CA
Relaxin receptor agonists for treatment of liver fibrosis$326,152
R01 · FY2021 · DK · contact PI
Engineering a long-acting relaxin agonist to treat liver fibrosis$308,708
R41 · FY2021 · DK
Relaxin receptor agonists for treatment of liver fibrosis$333,955
R01 · FY2020 · DK · contact PI
Relaxin receptor agonists for treatment of liver fibrosis$437,423
R01 · FY2019 · DK · contact PI
Relaxin receptor agonists for treatment of liver fibrosis$434,786
R01 · FY2018 · DK · contact PI
Small molecule agonists of insulin-like3 receptor for treatment of osteoporosis$315,019
R01 · FY2018 · AR · contact PI
Relaxin receptor agonists for treatment of liver fibrosis$446,411
R01 · FY2017 · DK · contact PI
Small molecule agonists of insulin-like3 receptor for treatment of osteoporosis$315,208
R01 · FY2017 · AR · contact PI
Small molecule agonists of insulin-like3 receptor for treatment of osteoporosis$255,200
R01 · FY2016 · AR · contact PI
Small molecule antagonists of relaxin receptor$288,313
U01 · FY2014 · CA · contact PI
Small molecule antagonists of relaxin receptor$297,403
U01 · FY2013 · CA · contact PI
Role of Y chromosomal genes in male fertility$175,725
R21 · FY2010 · HD · contact PI
Role of Y chromosomal genes in male fertility$228,495
R21 · FY2009 · HD · contact PI
Small molecule agonists of the relaxin receptor$25,000
R03 · FY2009 · MH · contact PI
Genetic basis of testicular descent$311,645
R01 · FY2008 · HD · contact PI
Targeting Relaxin Signaling in Prostate Cancer$150,000
R21 · FY2008 · CA · contact PI
Genetic basis of testicular descent$86
R01 · FY2008 · HD · contact PI
Genetic basis of testicular descent$321,078
R01 · FY2007 · HD · contact PI
Targeting Relaxin Signaling in Prostate Cancer$180,000
R21 · FY2007 · CA · contact PI
Genetic basis of testicular descent$330,668
R01 · FY2006 · HD · contact PI
Genetic basis of testicular descent$338,625
R01 · FY2005 · HD
Genetic basis of testicular descent$338,625
R01 · FY2004 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$176,108
R01 · FY2003 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$175,754
P01 · FY2002 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$170,976
R01 · FY2002 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$175,754
P01 · FY2001 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$165,997
R01 · FY2001 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$191,421
R01 · FY2000 · HD
GENETIC CONTROL OF EARLY TESTICULAR DESCENT$175,754
P01 · FY2000 · HD